PharmaShots | Incisive News in 3 Shots

Subscribe Now

health Canada

Samsung Bioepis’s Ontruzant (biosimilar, trastuzumab) Receives the Health Canada Approval for the Treatment of Breast & Gastric Cancer

Samsung Bioepis’s Ontruzant (biosimilar, trastuzumab) Receives the Health Canada Approval for the Treatment of Breast & Gastric Ca...

February 2, 2022

$Kite's Tecartus (brexucabtagene autoleucel) Receives Health Canada's Approval for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma$

Kite's Tecartus (brexucabtagene autoleucel) Receives Health Canada's Approval for the Treatment of Relapsed or Refractory Mantle C...

October 29, 2021

Sanofi's Sarclisa Combination Regimen Receives Health Canada's Approval for Multiple Myeloma

Sanofi's Sarclisa Combination Regimen Receives Health Canada's Approval for Multiple Myeloma

October 13, 2021

AbbVie's Rinvoq (upadacitinib) Receives the Health Canada Approval for the Treatment of Moderate to Severe Atopic Dermatitis

AbbVie's Rinvoq (upadacitinib) Receives the Health Canada Approval for the Treatment of Moderate to Severe Atopic Dermatitis

October 8, 2021

Amgen's Lumakras (sotorasib) Receives Health Canada's Approval for KRAS G12C-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Amgen's Lumakras (sotorasib) Receives Health Canada's Approval for KRAS G12C-Mutated Locally Advanced or Metastatic Non-Small Cell...

September 14, 2021

Merck Reports the Initiation of Rolling Submission to Health Canada for Molnupiravir to Treat COVID-19

Merck Reports the Initiation of Rolling Submission to Health Canada for Molnupiravir to Treat COVID-19

August 16, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us